Romania Demographic Events in 2023 Evenimente Demografice în Anul 2023 Vital registration: Subnationally representative GHDx Entry last modified on: May 31, 2024
Colombia Vital Statistics - Deaths 2023 (Preliminary) Defunciones no fetales año 2023 Año 2023 preliminar - (Defunciones no fetales ocurridas entre el 1 de enero y el 31 de diciembre de 2023, reportadas por la fuente hasta el 31 de enero de 2024) Vital registration: Subnationally representative - Urban-rural representative GHDx Entry last modified on: Mar 26, 2024
Romania Demographic Events in 2022 Evenimente Demografice în Anul 2022 Vital registration: Subnationally representative GHDx Entry last modified on: Oct 19, 2023
Iraq Annual Statistical Report with Kurdistan Region 2022 التقرير االحصائي السنوي Report: Epi surveillance - Inpatient - National vital registration - Nationally representative - Outpatient - Subnationally representative GHDx Entry last modified on: Mar 12, 2024
Colombia Vital Statistics - Deaths 2022 Estadísticas Vitales - EEVV - 2022; Defunciones No Fetales 2022 Vital registration: Subnationally representative - Urban-rural representative GHDx Entry last modified on: Sep 17, 2024
Premise Child Health COVID-19 Health Services Disruption Survey 2021 Survey: Cross-sectional - Individual GHDx Entry last modified on: Dec 12, 2022
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint Scientific literature GHDx Entry last modified on: Sep 13, 2022
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021. Survey: Epi surveillance GHDx Entry last modified on: Jul 13, 2022
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors Antistoffen coronavirus bij gemiddeld 18,6% van de donors Epi surveillance GHDx Entry last modified on: May 12, 2022
Costa Rica Statistical Yearbook 2021-2022 Anuario Estadístico 2021 - 2022 Report: Epi surveillance GHDx Entry last modified on: Oct 30, 2023
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5 Survey GHDx Entry last modified on: May 17, 2024
Evaluation of bacterial coinfections and susceptible antibiotic profiles in hospitalized COVID-19 patients in Koya district, Iraq Scientific literature GHDx Entry last modified on: Sep 17, 2024
ESBL and carbapenemase-producing Enterobacteriaceae in infectious pleural effusions: current epidemiology at Hôpital du Mali Scientific literature GHDx Entry last modified on: Sep 17, 2024
Japan Provisional Cases of Notifiable Diseases by Prefecture 2021 IDWR Surveillance Data Table 2021: Notifiable Diseases Epi surveillance: Subnationally representative GHDx Entry last modified on: Mar 29, 2024
India COVID-19 Crowdsourced Patient Database: Vaccine Doses Administered by State Epi surveillance GHDx Entry last modified on: Nov 15, 2022
Iraq Annual Statistical Report 2021 التقرير االحصائي السنوي Report: Epi surveillance - Inpatient - National vital registration - Nationally representative - Outpatient - Subnationally representative GHDx Entry last modified on: May 11, 2023
Japan Provisional Cumulative Cases of Diseases per Sentinel Reporting by Prefecture 2021 IDWR Surveillance Data Table 2021: Sentinel-Reporting Diseases (Weekly) Epi surveillance: Subnationally representative GHDx Entry last modified on: Apr 1, 2024
Microbiological Spectrum of Neutropenic Sepsis in Cancer Patients Admitted to a Tertiary Health Care Centre Scientific literature GHDx Entry last modified on: Sep 17, 2024
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Bhutan Royal Centre for Disease Control Quarterly Bulletin: First Quarter, Volume 25, January-March 2021 RCDC 1st Quarterly Bulletin Volume 25, Jan -March 2021 Epi surveillance: Subnationally representative GHDx Entry last modified on: Jan 17, 2023
Colombia Vital Statistics - Deaths 2021 Estadísticas Vitales - EEVV - 2021; Defunciones No Fetales 2021 Vital registration: Subnationally representative - Urban-rural representative GHDx Entry last modified on: Oct 28, 2024
Romania Demographic Events in 2021 Evenimente Demografice în Anul 2021 Vital registration: Subnationally representative GHDx Entry last modified on: Aug 17, 2022
Federation of Bosnia and Herzegovina Statistical Yearbook 2022 Statistički Godišnjak/ Ljetopis Federacije Bosne I Hercegovine 2022 Report: Discharge - Epi surveillance - Inpatient GHDx Entry last modified on: May 19, 2023
Emergence of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Gram Negative Non-Fermenters at Selected Hospitals of Northeast Ethiopia: A Prospective Cross-Sectional Study Scientific literature GHDx Entry last modified on: Sep 17, 2024
Benin Health Statistical Yearbook 2021 Annuaire Des Statistiques Sanitaires Annee 2021 Report: Epi surveillance - Nationally representative - Urban-rural representative GHDx Entry last modified on: Apr 12, 2024
The prevalence of Carbapenem Resistance Gram negative pathogens in a Tertiary Teaching Hospital in Jordan Scientific literature GHDx Entry last modified on: Sep 17, 2024
Saudi Arabia Monthly Epidemiology Report December 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Feb 6, 2024
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Saudi Arabia Monthly Epidemiology Report November 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Feb 6, 2024
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020 Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER) Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020 RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Aug 6, 2021
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4 Survey GHDx Entry last modified on: May 17, 2024
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase Survey: Individual - Interview GHDx Entry last modified on: Oct 21, 2022
Saudi Arabia Monthly Epidemiology Report October 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Feb 6, 2024
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1 ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION Survey GHDx Entry last modified on: May 12, 2022
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October Epi surveillance GHDx Entry last modified on: May 12, 2022
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Saudi Arabia Monthly Epidemiology Report September 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Feb 6, 2024
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020 Epi surveillance GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint Scientific literature GHDx Entry last modified on: Oct 5, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Apr 1, 2024
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint Scientific literature: Epi surveillance GHDx Entry last modified on: Apr 8, 2022
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020 COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020 Epi surveillance GHDx Entry last modified on: May 12, 2022